Tag Archives: Regulatory Reform
Making the most of complementary medicines reforms
In March this year the TGA finally started rolling out the long awaited Complementary Medicine Reforms. One of the most significant changes for sponsors of listed complementary medicines is the abolition of the “free text” box for indications. All … Continue reading
Independent Review of Medicines and Medical Devices Regulation
This week, Pharma in Focus interviewed one of our Senior Regulatory consultants, Dr Greg Pearce, for his commentary on the stage 1 report from the independent review of Medicines and Medical Devices regulation. Released last month, the report is currently … Continue reading
Industry Insight – Ready for Joint Implant Reclassification?
Industry Insight is a new regular feature of Eye Spy. This month we address the latest challenge for sponsors of medical devices. Continue reading
Business Process Reform at the TGA
The TGA are proposing the most significant changes to the evaluation process for prescription medicines in nearly 20 years. In this article, the proposed changes are summarised and the potential effects for industry are discussed. Continue reading
